Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients

• Published in: Journal of the American Society of Nephrology Vol. 9; no. 7; pp. 1277 - 1284
• Main Authors: SHOJI, T, NISHIZAWA, Y, KAWAGISHI, T, KAWASAKI, K, TANIWAKI, H, TABATA, T, INOUE, T, MORII, H
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott Williams & Wilkins 01.07.1998
• Subjects: Adult; Aortic Diseases - blood; Aortic Diseases - diagnosis; Aortic Diseases - epidemiology; Aortic Diseases - etiology; Arteriosclerosis - blood; Arteriosclerosis - diagnosis; Arteriosclerosis - epidemiology; Arteriosclerosis - etiology; Atherosclerosis (general aspects, experimental research); Biological and medical sciences; Biomarkers - blood; Blood and lymphatic vessels; Blood Flow Velocity; Cardiology. Vascular system; Female; Humans; Kidney Failure, Chronic - blood; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - therapy; Lipoproteins - blood; Lipoproteins, IDL; Male; Medical sciences; Middle Aged; Reference Values; Regression Analysis; Renal Dialysis; Risk Factors; Sensitivity and Specificity; Kidney disease; Human; Urinary system disease; Hemodialysis; Cardiovascular disease; Terminal stage; Increase; Lipoprotein; Statistical study; Vascular disease; Characterization; Extrarenal dialysis; Treatment; Atherosclerosis; Risk factor; Renal failure; Complication

Patients with chronic renal failure often show accumulation of intermediate-density lipoprotein (IDL). Because recent studies have emphasized the atherogenicity of IDL in the general population, we evaluated the relationship between this lipoprotein and aortic atherosclerosis in uremic patients trea...